Potential effects of racial and ethnic disparities in meeting Medicare medication therapy management eligibility criteria

Medication therapy management (MTM) has the potential to play an instrumental role in reducing racial and ethnic disparities in health care. However, previous research has found that blacks and Hispanics are less likely to be eligible for MTM. The purpose of the current study was to examine the potential effects of MTM eligibility criteria on racial and ethnic disparities in health outcomes.

[1]  B. Banahan,et al.  Evaluation Of Pharmacy Quality Alliance (Pqa) Measures Among Medicaid Beneficiaries With Persistant Asthma , 2014 .

[2]  M. Cunningham,et al.  Outcomes Of In-Person Versus Telephonic Medication Therapy Management (Mtm) Services Provided To Medicare Part D Beneficiaries , 2014 .

[3]  Ya-Chen Tina Shih,et al.  Potential health implications of racial and ethnic disparities in meeting MTM eligibility criteria. , 2013, Research in social & administrative pharmacy : RSAP.

[4]  Junling Wang,et al.  Historical trend of disparity implications of Medicare MTM eligibility criteria. , 2013, Research in social & administrative pharmacy : RSAP.

[5]  Mary T. Roth,et al.  Individualized Medication Assessment and Planning: Optimizing Medication Use in Older Adults in the Primary Care Setting , 2013, Pharmacotherapy.

[6]  J. Farley,et al.  Retrospective Analysis of Estimated Cost Avoidance Following Pharmacist-Provided Medication Therapy Management Services , 2013, Journal of pharmacy practice.

[7]  J. Lave,et al.  Medicare Part D and potentially inappropriate medication use in the elderly. , 2012, The American journal of managed care.

[8]  Denys T. Lau,et al.  Medicare Part D and Quality of Prescription Medication Use in Older Adults , 2011, Drugs & aging.

[9]  Carolyn M. Brown,et al.  Impact of telephone medication therapy management on medication and health-related problems, medication adherence, and Medicare Part D drug costs: a 6-month follow up. , 2011, The American journal of geriatric pharmacotherapy.

[10]  A. Zaslavsky,et al.  The impact of Medicare Part D on hospitalization rates. , 2011, Health services research.

[11]  Cyril F. Chang,et al.  Comparisons of changes over time in per capita health expenditures across racial and ethnic groups , 2010 .

[12]  Maarten L. Buis,et al.  Stata Tip 87: Interpretation of Interactions in Nonlinear Models , 2010 .

[13]  W. Cushman,et al.  Disparity implications of Medicare eligibility criteria for medication therapy management services. , 2010, Health services research.

[14]  S. Lee,et al.  Racial differences in medication adherence: A cross-sectional study of Medicare enrollees. , 2010, The American journal of geriatric pharmacotherapy.

[15]  T. Fera,et al.  Diabetes Ten City Challenge: final economic and clinical results. , 2009, Journal of the American Pharmacists Association : JAPhA.

[16]  L. Ried,et al.  A medication therapy management program's impact on low-density lipoprotein cholesterol goal attainment in Medicare Part D patients with diabetes. , 2009, Journal of the American Pharmacists Association : JAPhA.

[17]  A. Burns.  Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0). , 2008, Journal of the American Pharmacists Association : JAPhA.

[18]  S. Sutherland,et al.  The Asheville Project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia. , 2008, Journal of the American Pharmacists Association : JAPhA.

[19]  N. Miller,et al.  Utilizing new prescription drugs: disparities among non-Hispanic whites, non-Hispanic blacks, and Hispanic whites. , 2007, Health services research.

[20]  S. White-Means,et al.  The economic implications of the racial and ethnic disparities in the use of selective serotonin reuptake inhibitors* , 2007, Current medical research and opinion.

[21]  D. Malone,et al.  Characteristics of Older Adults Who Meet the Annual Prescription Drug Expenditure Threshold for Medicare Medication Therapy Management Programs , 2007, Journal of managed care pharmacy : JMCP.

[22]  Charles E. Menifield,et al.  Disparities in health care: minority elders at risk. , 2007, The ABNF journal : official journal of the Association of Black Nursing Faculty in Higher Education, Inc.

[23]  N. Miller,et al.  Disparities in Access to Essential New Prescription Drugs between Non-Hispanic Whites, Non-Hispanic Blacks, and Hispanic Whites , 2006, Medical care research and review : MCRR.

[24]  Hhs Centers for Medicare Medicare Services.  Medicare program; Medicare prescription drug benefit. Final rule. , 2005, Federal register.

[25]  Leiyu Shi,et al.  Primary care experience and racial disparities in self-reported health status. , 2004, The Journal of the American Board of Family Practice.

[26]  J. Doshi,et al.  Impact of prescription coverage on hospital and physician costs: a case study of medicare beneficiaries with chronic obstructive pulmonary disease. , 2004, Clinical therapeutics.

[27]  M. Beers,et al.  Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. , 2003, Archives of internal medicine.

[28]  D. Christensen,et al.  The asheville project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. , 2003, Journal of the American Pharmaceutical Association.

[29]  B. Briesacher,et al.  Racial and Ethnic Disparities in Prescription Coverage and Medication Use , 2003, Health care financing review.

[30]  Randall S. Brown,et al.  Racial Disparities in Prescription Drug Use Among Dually Eligible Beneficiaries , 2003, Health care financing review.

[31]  Adrienne Y. Stith,et al.  Unequal treatment: confronting racial and ethnic disparities in health care. , 2003 .

[32]  J. Samet,et al.  Food and Drug Administration , 2007, BMJ : British Medical Journal.

[33]  B H Chang,et al.  Risk Adjustment for Measuring Health Outcomes: An Application in VA Long term Care , 2001, American journal of medical quality : the official journal of the American College of Medical Quality.

[34]  M. Gornick.  Disparities in Medicare Services: Potential Causes, Plausible Explanations, and Recommendations , 2000, Health care financing review.

[35]  M. Gornick,et al.  The Association of Race/Socioeconomic Status and Use of Medicare Services: A Little‐Known Failure in Access to Care , 1999, Annals of the New York Academy of Sciences.

[36]  P. Eggers,et al.  Effects of race and income on mortality and use of services among Medicare beneficiaries. , 1996, The New England journal of medicine.

[37]  L. Mintz,et al.  Risk Adjustment , 1990 .

[38]  G. H. Moore,et al.  Consumer Price Index , 1993 .

[39]  R. Andersen,et al.  A framework for the study of access to medical care. , 1974, Health services research.

[40]  A. Marcus.  The hydrolysis of hydrocortisone phosphate in essentially neutral solutions. , 1960, Journal of the American Pharmaceutical Association. American Pharmaceutical Association.